MARY TYSON: Open Payments
NPI 1780669218 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,797 in 143 payments from 11 companies in 2025. Trend: 2023 $3,345 · 2024 $3,341 · 2025 $2,797
Food & beverage: $2,691Education: $106
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $854 |
| Alkermes, Inc. | 17 | $353 |
| Vanda Pharmaceuticals Inc. | 9 | $282 |
| Lundbeck LLC | 11 | $253 |
| Janssen Pharmaceuticals, Inc | 11 | $246 |
| Otsuka America Pharmaceutical, Inc. | 10 | $204 |
| E.R. Squibb & Sons, L.L.C. | 9 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $145 |
| Neurocrine BioSciences, Inc. | 6 | $139 |
| Axsome Therapeutics, Inc. | 5 | $100 |
Products named: UZEDY, ARISTADA, ABILIFY ASIMTUFII, FANAPT, AUSTEDO XR, INVEGA SUSTENNA, REXULTI, COBENFY.
Industry payments across GA — which companies pay providers there.
